Real-world impact and effectiveness of MenACWY-TT

Villena, R; Kriz, P; Htar, MTT; Burman, C; Findlow, J; Balmer, P; Jodar, L

Htar, MTT (通讯作者),Pfizer Inc, Vaccine Med Dev & Sci Clin Affairs, 23-25 Ave Docteur Lannelongue, F-14 Paris, France.

HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023; 19 (2):

Abstract

In response to escalating cases of serogroup W (MenW) invasive meningococcal disease (IMD), multiple countries introduced quadrivalent conjugate MenAC......

Full Text Link